ERBB2 and neoplasm: Nevertheless, patients with a tumor size > 2 cm, lymph node-positive, grade III, clinical-stage II + III, or HER2 positive had significantly shorter survival times, whereas HR positivity remarkably improved the survival of BC patients (log-rank P < 0.05, Table 1).